Guotai Junan expects Hong Kong stocks to fluctuate upward in an N-shaped pattern next year to explore domestic demand and improve investment opportunities. Chen Ximiao, chief analyst of Guotai Junan's overseas strategy, said that looking forward to 2025, the disturbance factors in the Hong Kong stock market from the external environment will continue, and the pace of interest rate cuts by the Federal Reserve under overseas inflation, policy restrictions in areas such as strong US dollar and tariffs, and game friction among big countries will continue. However, the domestic policy thinking is clear, economic expectations are expected to stabilize under the financial impetus, and the profitability of molecular enterprises will improve, and the industrial chain will be able to cope with it. She said that in 2025, the sensitivity of the Hong Kong stock market to external shocks is expected to decline, and more attention should be paid to returning to its own logic. For the trend of Hong Kong stocks in 2025, it is expected to be dominated by the upward pattern of N-shaped shocks, and there are many opportunities for flexibility during the stage. In 2025, we should still actively look for the structure, and focus on the barbell strategy to shift the weight of the two ends. We need to pay more attention to the configuration rhythm and pay attention to the repair opportunities of some domestic products.CLP Xingfa: At present, the company is not involved in quantum technology or application. CLP Xingfa said on the interactive platform on December 11 that the company is not involved in quantum technology or application at present.Modern Pharmaceuticals: Sinopharm Zhijun, the holding subsidiary, obtained the drug registration certificate of Cefotaxime Tablets. Modern Pharmaceuticals announced that Sinopharm Zhijun Pharmaceutical Co., Ltd., the holding subsidiary, recently received the Drug Registration Certificate of Cefotaxime Tablets approved and issued by National Medical Products Administration. Cefopoxime axetil tablets are the third generation cephalosporins taken orally, which are used to treat upper respiratory tract infections and lower respiratory tract infections caused by sensitive bacteria. In 2023, the global sales of preparations will be USD 370 million, and the sales of public hospitals nationwide will be RMB 102 million. The accumulative R&D investment of Sinopharm Zhijun is about RMB 28.45 million. Obtaining the registration certificate will enrich the company's product line, increase market competitiveness and have a positive impact on the company's future development. However, drug sales are easily affected by factors such as policies and market environment, and there are uncertainties.
It is reported that Walgreens Boots Alliance is negotiating to sell itself to a private equity company, which will delist the drugstore chain. The company's share price has been declining for nearly ten years. According to informed sources, Wobolian and Sycamore Partners have been discussing a deal, which may be completed as early as early next year, provided that the negotiations do not break down. It is reported that the market value of Wobolian peaked at more than 100 billion US dollars in 2015, but it has shrunk to about 7.5 billion US dollars since then.South Korea's chaebol triggered public outrage among investors, and regulators began to show their swords and rectify. For half a century, South Korea's oligarchs have dominated almost every economic field. They are in charge of corporate giants, making waves in political circles, carefully planning mysterious business transactions, and sacrificing the interests of shareholders while making profits for themselves. Regulators and investors began to show their swords. South Korean President Yin Xiyue announced that martial law was hastily lifted, or faced the fate of stepping down. The current political situation may accelerate this counterattack process again.European stocks opened lower, European Stoxx 50 index fell 0.15%, European stocks opened lower, European Stoxx 50 index fell 0.15%, German DAX index fell 0.03%, British FTSE 100 index fell 0.3%, and French CAC40 index fell 0.3%.
Comments on Hong Kong stocks: Hang Seng Index fell by 0.77%, Hang Seng Technology Index fell by 1.31%, Hong Kong stocks closed, Hang Seng Technology Index fell by 0.77%, Hang Seng Technology Index fell by 1.31%, dropped by over 5%, and JD.COM Group and Meituan fell by over 2%.Yao Anna became the brand ambassador of Baique Ling, and Baique Ling officially announced Yao Anna as the brand ambassador on December 11th.On the 11th, iron ore fell by 1.64%, and the latest main contract positions changed as follows. According to the exchange data, as of December 11th, the main contract iron ore was closed at 2501, up or down by -1.64%, with a turnover of 165,400 lots. The position data showed that the top 20 seats were clear, and the difference position was 14,975 lots. Iron ore futures contracts totaled 429,100 lots, a decrease of 195,200 lots from the previous day. The first 20 seats in the contract held 462,200 lots, a decrease of 6,055 lots from the previous day. There were 481,400 short positions in the top 20 seats of the contract, an increase of 7,172 lots over the previous day. (Sina Futures)
Strategy guide 12-14
Strategy guide
Strategy guide 12-14
Strategy guide 12-14
Strategy guide
12-14